Literature DB >> 16630522

Dealing with non-cancerous findings on prostate biopsy.

Timothy C Brand1, Gregory P Thibault, Joseph W Basler.   

Abstract

Most prostate biopsies do not show malignancy. The proper management of non-cancerous pathologic findings of the prostate is controversial. For this article, we reviewed the current literature for indications for repeat prostate biopsy after initial biopsies demonstrated non-cancerous prostatic tissue or benign prostatic hyperplasia. This review includes discussions of management of asymptomatic prostatitis and how it may affect prostate-specific antigen, and also the management of several potentially premalignant lesions such as atrophy, atypical small acinar proliferation, and high-grade prostatic intraepithelial neoplasia. There is a paucity of randomized trials in this area and, considering the high number of biopsies with non-malignant findings, we conclude that more investigation is warranted in this area.

Entities:  

Mesh:

Year:  2006        PMID: 16630522     DOI: 10.1007/s11934-006-0020-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  47 in total

Review 1.  Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report.

Authors:  D G Bostwick; R Montironi; I A Sesterhenn
Journal:  Scand J Urol Nephrol Suppl       Date:  2000

2.  Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen.

Authors:  J M Potts
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

3.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Variation in patterns of practice in diagnosing screen-detected prostate cancer.

Authors:  Robert K Nam; Ants Toi; John Trachtenberg; Michael A S Jewett; Laurence Klotz; Neil Fleshner; P Scott Bagnell; Joan Sweet; Linda Sugar; Steven A Narod
Journal:  BJU Int       Date:  2004-12       Impact factor: 5.588

5.  Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study.

Authors:  Lucila Heloisa Simardi; Marcos Tobias-MacHado; Guilherme Tommasi Kappaz; Patricia Taschner Goldenstein; Jeannette M Potts; Eric Roger Wroclawski
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

6.  Treatment of chronic prostatitis lowers serum prostate specific antigen.

Authors:  Caleb B Bozeman; Brett S Carver; James A Eastham; Dennis D Venable
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

7.  Precipitating antigens of the normal human prostate.

Authors:  R J Ablin; W A Soanes; P Bronson; E Witebsky
Journal:  J Reprod Fertil       Date:  1970-08

8.  Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies.

Authors:  Vincenzo Scattoni; Marco Roscigno; Massimo Freschi; Alberto Briganti; Gemma Viola Fantini; Roberto Bertini; Andrea Salonia; Francesco Montorsi; Patrizio Rigatti
Journal:  Urology       Date:  2005-11       Impact factor: 2.649

9.  High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population.

Authors:  Neriman Gokden; Kimberly A Roehl; William J Catalona; Peter A Humphrey
Journal:  Urology       Date:  2005-03       Impact factor: 2.649

Review 10.  Contemporary pathology of prostate cancer.

Authors:  David G Bostwick; Junqi Qian; Cory Schlesinger
Journal:  Urol Clin North Am       Date:  2003-05       Impact factor: 2.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.